Nasdaq IPOs

Generation Bio, a preclinical biotech developing gene therapies for rare diseases, raised $200 million by offering 10.5 million shares at $19, the high end of the revised range of $18 to $19. The company offered 0.5 million more shares than anticipated after upwardly revising its

GS Acquisition Holdings II, the second blank check company formed by Goldman Sachs, filed on Thursday with the SEC to raise up to $700 million in an initial public offering. The New York, NY-based company plans to raise $700 million by offering 70 million units at $10. Each unit

As indexes like the Nasdaq Composite and Nasdaq-100 hit all-time highs, there are many signs that the economy is on the road to recovery.

Lantern Pharma, a biotech redeveloping abandoned drugs for non-small cell lung cancer, raised $26 million by offering 1.8 million shares at $15, the low end of the range of $15 to $17. Lantern Pharma plans to list on the Nasdaq under the symbol LTRN. ThinkEquity acted as a lead m

Capstar Special Purpose Acquisition, a blank check company formed by investment firm Capstar Partners, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The Austin, TX-based company plans to raise $200 million by offering 20 million units a

Generation Bio, a preclinical biotech developing gene therapies for rare diseases, raised the proposed deal size for its upcoming IPO on Thursday. The Cambridge, MA-based company now plans to raise $185 million by offering 10 million shares at a price range of $18 to $19. The com

Avidity Biosciences, a preclinical biotech developing antibody therapies for muscle disorders, raised the proposed deal size for its upcoming IPO on Thursday. The La Jolla, CA-based company now plans to raise $210 million by offering 12 million shares at a price range of $17 to $

uCloudlink, a mobile data traffic sharing marketplace in China, raised $36 million by offering 2 million ADSs at $18, the low end of the range of $18.00 to $20.50. The company offered 0.6 million fewer ADSs than anticipated. At pricing, the company commands a fully diluted market

Online used car dealer Vroom (VRM) popped 118% on Tuesday, the best first-day return for a tech IPO since China's Qutoutiao (QTT; +128% pop) in September 2018. Among US-based tech IPOs, Vroom notched the best pop since Nutanix (NTNX; +131%) in September 2016.

Three large preclinical biotech IPOs are slated to begin trading on Friday, the most ever in a single week.Vaxcyte (PCVX) is developing next-generation pneumonia vaccines, a $7 billion market, and expects to begin clinical trials for its lead candidate in the 2H21. Avidity Biosci

Kensington Capital Acquisition, a blank check company targeting the automotive industry, filed on Tuesday with the SEC to raise up to $175 million in an initial public offering. The Westbury, NY-based company plans to raise $175 million by offering 17.5 million units at $10. Each

Dun & Bradstreet, which provides commercial data analytics services, filed on Tuesday with the SEC to raise up to $1.0 billion in an initial public offering. The company was taken private in February 2019 by an investor consortium led by shareholders Cannae Holdings (NYSE: CN

Dun & Bradstreet, which provides commercial data analytics services, filed on Tuesday with the SEC to raise up to $1.0 billion in an initial public offering. The company was taken private in February 2019 by an investor consortium led by shareholders Cannae Holdings (NYSE: CN

Hudson Executive Investment, a blank company formed by Hudson Executive Capital targeting fintech or healthcare, raised $360 million by offering 36 million shares at $10. The company originally filed to offer 30 million units. Units consist of one share of common stock and one ha

Vroom, an online used car dealer operating throughout the US, raised $468 million by offering 21.3 million shares at $22, above the range of $18 to $20. The company originally filed to offer 18.8 million shares at a range of $15 to $17, before raising the range on Friday. At pric

Fusion Acquisition, a blank check company targeting the financial services industry, filed on Monday with the SEC to raise up to $250 million in an initial public offering. The New York, NY-based company plans to raise $250 million by offering 25 million units at $10. Each unit c

Lemonade, a mobile-based property and casualty insurer, filed on Monday with the SEC to raise up to $100 million in an initial public offering. Lemonade is focused on digitizing insurance end-to-end, leveraging data and artificial intelligence to power all aspects of its platform

Nasdaq Sees a Strong IPO Market through Fall

Avidity Biosciences, a preclinical biotech developing antibody therapies for muscle disorders, announced terms for its IPO on Monday. The La Jolla, CA-based company plans to raise $150 million by offering 10 million shares at a price range of $14 to $16. At the midpoint of the pr

Generation Bio, a preclinical biotech developing gene therapies for rare diseases, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $126 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint of the proposed ran